1,494
Views
4
CrossRef citations to date
0
Altmetric
Letter

Successful maternal and fetal outcome in a rare case of essential Thrombocythemia with pregnancy using Interferon alpha

, , , &
Pages 319-321 | Received 12 Jul 2011, Accepted 05 Aug 2011, Published online: 13 Sep 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Martin Griesshammer, Parvis Sadjadian & Kai Wille. (2018) Contemporary management of patients with BCR-ABL1-negative myeloproliferative neoplasms during pregnancy. Expert Review of Hematology 11:9, pages 697-706.
Read now

Articles from other publishers (3)

Yoshinori Hashimoto, Rina Hosoda, Hiromi Omura & Takayuki Tanaka. (2021) Marked Rebound of Platelet Count in the Early Postpartum Period in a Patient with Essential Thrombocythemia. Case Reports in Hematology 2021, pages 1-5.
Crossref
Hassan Awada, Maria Voso, Paola Guglielmelli & Carmelo Gurnari. (2020) Essential Thrombocythemia and Acquired von Willebrand Syndrome: The Shadowlands between Thrombosis and Bleeding. Cancers 12:7, pages 1746.
Crossref
Kazuya Sakai, Akane Ueda, Masaaki Hasegawa & Yasunori Ueda. (2017) Efficacy and safety of interferon alpha for essential thrombocythemia during pregnancy: two cases and a literature review. International Journal of Hematology 108:2, pages 203-207.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.